Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | MGLL | Q99685 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 3/20 | 0.55 |
| ▸ | MAOB | P27338 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | HTR6 | P50406 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.42 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.42 |
| ▸ | NOS1 | P29475 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diphenylsulfane SCHEMBL451796 | 1.00 | HPGD (0.56) | HPGDMAPTSMN1; SMN2MGLLHSD17B10 | |
| Diphenylsulfane SCHEMBL7109540 | 0.96 | HPGD (0.60) | HPGDMAPTSMN1; SMN2MGLLHSD17B10 | |
| Diphenylsulfane SCHEMBL27714827 | 0.96 | HPGD (0.60) | HPGDMAPTSMN1; SMN2MGLLHSD17B10 | |
| Diphenylsulfane SCHEMBL28332331 | 0.96 | HPGD (0.60) | HPGDMAPTSMN1; SMN2MGLLHSD17B10 | |
| Diphenylsulfane SCHEMBL452 | 0.96 | HPGD (0.60) | HPGDMAPTSMN1; SMN2MGLLHSD17B10 | |
| Diphenylsulfane SCHEMBL27611905 | 0.96 | HPGD (0.60) | HPGDMAPTSMN1; SMN2MGLLHSD17B10 | |
| SCHEMBL23277364 | 0.92 | MAOA (0.62) | HPGDMAPTSMN1; SMN2MGLLHSD17B10 | |
| Diphenylsulfane SCHEMBL18043143 | 0.92 | HPGD (0.56) | HPGDMAPTSMN1; SMN2MGLLHSD17B10 | |
| Diphenylsulfane SCHEMBL1271354 | 0.92 | HPGD (0.56) | HPGDMAPTSMN1; SMN2MGLLHSD17B10 | |
| SCHEMBL795030 | 0.92 | MAOA (0.62) | HPGDMAPTSMN1; SMN2MGLLHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4584146-A | Tetrakis(2,6-di-t-butyl-4-substituted phenyl)4,4'-bisphenyl diphosphites | THE B. F. GOODRICH COMPANY (US) | 1986-04-22 | — | — | US | claimed |
| US-11254650-B1 | Use of pnictogenium compounds in carbon-carbon bond formation | SOUTHEASTERN LOUISIANA UNIVERSITY (US) | 2022-02-22 | — | — | US | disclosed |
| CN-109312056-B | Epoxy compound, curable composition containing same, and cured product obtained by curing curable composition | JXTG能源株式会社 | 2021-10-01 | — | — | CN | disclosed |
| CN-109311906-B | Epoxy compound, curable composition containing same, and cured product obtained by curing curable composition | JXTG能源株式会社 | 2021-08-03 | — | — | CN | disclosed |
| CN-113072684-A | Curable composition and cured product obtained by curing same | JXTG能源株式会社 | 2021-07-06 | — | — | CN | disclosed |
| CN-109071776-B | Curable composition and cured product obtained by curing same | JXTG能源株式会社 | 2021-06-08 | — | — | CN | disclosed |
| EP-1888727-B1 | NEW DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS | PRONOVA BIOPHARMA NORGE AS (NO) | 2015-04-15 | — | — | EP | disclosed |
| CN-103058867-B | Novel DHA derivatives for and uses thereof as medicament | PRONOVA BIOCARE AS | 2015-03-25 | — | — | CN | disclosed |
| US-8618165-B2 | Compounds | PRONOVA BIOPHARMA NORGE AS (NO) | 2013-12-31 | — | — | US | disclosed |
| CN-103058867-A | Fatty acid analogues, i.e. dha derivatives for uses as a medicament | PRONOVA BIOCARE AS | 2013-04-24 | — | — | CN | disclosed |
| EP-0004773-B1 | 17-BETA-THIOCARBOXYLIC ACID ESTERS OF 4-HALO-3-OXOANDROST-4-ENES, THEIR PHARMACEUTICAL USE AND PROCESSES FOR THEIR PREPARATION | SYNTEX (U.S.A.) INC. (US) | 1981-04-29 | — | — | EP | disclosed |
| US-4264499-A | PSYCHOTROPIC AGENTS, ANXIOLYTICS, ANTICONVULSANTS, HYOTICS | SHIONOGI & CO., LTD. (JP) | 1981-04-28 | — | — | US | disclosed |
| EP-0004741-B1 | THIO ETIANIC ACID DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL USE | SYNTEX (U.S.A.) INC. (US) | 1981-01-28 | — | — | EP | disclosed |
| US-4231930-A | PSYCHOTROPIC AGENTS, ANXIOLYTICS, ANTICONVULSANTS, HYPNOTICS | SHIONOGI & CO., LTD. (JP) | 1980-11-04 | — | — | US | disclosed |
| US-4198403-A | ANTIINFLAMMATORY AGENTS | SYNTEX (U.S.A.) INC. (US) | 1980-04-15 | — | — | US | disclosed |
| US-4188385-A | ANTIINFLAMMATORY STERIODS | SYNTEX (U.S.A.) INC. (US) | 1980-02-12 | — | — | US | disclosed |
| US-4187301-A | ANTIINFLAMMATORY AGENTS | SYNTEX (U.S.A.) INC. (US) | 1980-02-05 | — | — | US | disclosed |
| EP-0004773-A2 | 17-Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes, their pharmaceutical use and processes for their preparation | SYNTEX (U.S.A.) INC. (US) | 1979-10-17 | — | — | EP | disclosed |
| EP-0004741-A2 | Thio etianic acid derivatives, their preparation and pharmaceutical use | SYNTEX (U.S.A.) INC. (US) | 1979-10-17 | — | — | EP | disclosed |
| EP-0004320-A1 | 1-Substituted-thiomethyltriazolobenzodiazepines, preparation thereof, their use, and a pharmaceutical composition | SHIONOGI & CO., LTD. (JP) | 1979-10-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11254650-B1 | Use of pnictogenium compounds in carbon-carbon bond formation | MASTL, PHYKPL, HRH3 | HPGD 2672/4885MAPT 4685/4885SMN1; SMN2 4740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.